Cardiol Therapeutics Inc. (CRDL) Institutional Ownership

Ownership Summary

According to SEC filings for the period ending September 2025, Cardiol Therapeutics Inc. (NASDAQ:CRDL) is held by 48 institutional firms.

• These investors collectively held 12.1% of the company's total shares outstanding in September 2025, up from 11.1% in June 2025.
• On a quarter-over-quarter basis, institutional holdings shifted by 25.40%, with a year-over-year an increase of 17.07% in the count of filers.
• Among the 48 institutional holders of Cardiol Therapeutics, 21 added to their stakes while 13 trimmed their positions and 14 held steady.
• The aggregate institutional position in Cardiol Therapeutics now stands at 7.30Mn shares as of September 2025, after investors increased their holdings (up by 1.48Mn shares quarter on quarter which is up 2.35Mn shares year over year).
• With 2.63Mn shares, Tejara Capital Ltd commands the largest institutional position in Cardiol Therapeutics as of September 30, 2025, equating to 4.37% of the company.
• Among the most significant buyers of Cardiol Therapeutics during September 2025 were MARSHALL WACE, LLP (544.32K), BANK OF AMERICA CORP /DE/ (524.60K), CITADEL ADVISORS LLC (463.46K), GOLDMAN SACHS GROUP INC (264.30K), TWO SIGMA INVESTMENTS, LP (232.34K).
• Leading sellers of Cardiol Therapeutics stock in September 2025 included Tejara Capital Ltd (635.70K), AdvisorShares Investments LLC (300.00K), PVG ASSET MANAGEMENT CORP (141.38K), ENVESTNET ASSET MANAGEMENT INC (133.05K), UBS Group AG (85.75K).
• The top 10 institutional holders of Cardiol Therapeutics for the quarter ending September 2025 included Tejara Capital Ltd (2.63Mn), AdvisorShares Investments LLC (557.39K), BANK OF AMERICA CORP /DE/ (551.05K), MARSHALL WACE, LLP (544.32K), CITADEL ADVISORS LLC (463.46K), GOLDMAN SACHS GROUP INC (321.80K), MMCAP International Inc. SPC (293.06K), TWO SIGMA INVESTMENTS, LP (232.34K), MORGAN STANLEY (156.33K), Virtu Financial LLC (144.06K).